See more : The a2 Milk Company Limited (ACOPF) Income Statement Analysis – Financial Results
Complete financial analysis of Outset Medical, Inc. (OM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Outset Medical, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Labrador Iron Mines Holdings Limited (LBRMF) Income Statement Analysis – Financial Results
- Yelp Inc. (YELP) Income Statement Analysis – Financial Results
- China Suntien Green Energy Corporation Limited (CSGEF) Income Statement Analysis – Financial Results
- Kingsmen Resources Ltd. (KNGRF) Income Statement Analysis – Financial Results
- PT Bank Nationalnobu Tbk (NOBU.JK) Income Statement Analysis – Financial Results
Outset Medical, Inc. (OM)
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 130.38M | 115.38M | 102.60M | 49.94M | 15.08M | 2.01M |
| Cost of Revenue | 101.38M | 97.54M | 94.99M | 62.97M | 32.88M | 8.12M |
| Gross Profit | 29.00M | 17.83M | 7.61M | -13.04M | -17.80M | -6.12M |
| Gross Profit Ratio | 22.24% | 15.46% | 7.42% | -26.11% | -118.07% | -304.68% |
| Research & Development | 57.31M | 48.86M | 36.74M | 28.85M | 23.33M | 22.92M |
| General & Administrative | 45.23M | 40.52M | 36.32M | 30.51M | 8.92M | 6.25M |
| Selling & Marketing | 96.23M | 89.48M | 65.07M | 45.07M | 20.26M | 11.28M |
| SG&A | 141.46M | 130.00M | 101.39M | 75.58M | 29.18M | 17.53M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 198.77M | 178.85M | 138.13M | 104.43M | 52.51M | 40.45M |
| Cost & Expenses | 300.15M | 276.39M | 233.12M | 167.40M | 85.39M | 48.57M |
| Interest Income | 10.17M | 3.29M | 498.00K | 526.00K | 2.49M | 1.71M |
| Interest Expense | 12.68M | 3.57M | 1.72M | 2.37M | 4.26M | 4.64M |
| Depreciation & Amortization | 5.81M | 6.28M | 6.18M | 3.76M | 1.94M | 1.49M |
| EBITDA | -153.79M | -152.81M | -124.86M | -114.85M | -62.09M | -43.62M |
| EBITDA Ratio | -117.96% | -136.71% | -126.72% | -235.24% | -436.97% | -2,181.61% |
| Operating Income | -169.77M | -161.02M | -130.52M | -117.47M | -70.31M | -46.56M |
| Operating Income Ratio | -130.22% | -139.56% | -127.21% | -235.24% | -466.29% | -2,320.03% |
| Total Other Income/Expenses | -2.50M | -1.64M | -1.22M | -4.03M | 2.03M | -3.19M |
| Income Before Tax | -172.27M | -162.66M | -131.74M | -121.49M | -68.28M | -49.76M |
| Income Before Tax Ratio | -132.14% | -140.98% | -128.40% | -243.30% | -452.84% | -2,479.07% |
| Income Tax Expense | 523.00K | 295.00K | 199.00K | -794.00K | 20.00K | 25.00K |
| Net Income | -172.80M | -162.96M | -131.94M | -120.70M | -68.30M | -49.78M |
| Net Income Ratio | -132.54% | -141.24% | -128.59% | -241.71% | -452.97% | -2,480.32% |
| EPS | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| EPS Diluted | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| Weighted Avg Shares Out | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
| Weighted Avg Shares Out (Dil) | 49.59M | 48.16M | 45.59M | 42.72M | 42.33M | 30.08M |
Class Action Filed Against Outset Medical, Inc. (OM) - October 28, 2024 Deadline to Join - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:OM). Such investors are advised to contact Danielle Peyton at...
October 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against OM
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Outset Medical, Inc.
LOS ANGELES, CA / ACCESSWIRE / October 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM) for violations of 10(b)...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Outset Medical, Inc. Lawsuit - OM
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for...
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company")...
Levi & Korsinsky Reminds Outset Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - OM
NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on...
Outset Medical (OM) Faces Delisting Threat Amidst Regulatory Woes and Investor Lawsuit - Hagens Berman
OM Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, CA / ACCESSWIRE / October 14, 2024 / Outset Medical, Inc. (NASDAQ:OM) is facing a perilous situation as it grapples with a potential delisting from the Nasdaq and a...
Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights – OM
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM) of a class action securities lawsuit.
Source: https://incomestatements.info
Category: Stock Reports